The anticonvulsant zonisamide scavenges free radicals

Epilepsy Research

Volumn 30, Issue 2, 1998, Pages 153-158

  Mori, Akitane ^a   Noda, Yasuko ^a   Packer, Lester ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antiepileptics; Electron spin resonance; Free radicals; Hydroxyl radical; Nitric oxide; Zonisamide

Indexed keywords

FREE RADICAL; ZONISAMIDE;

ANTICONVULSANT THERAPY; ARTICLE; DRUG EFFECT; DRUG MECHANISM; ELECTRON SPIN RESONANCE; EPILEPSY; PRIORITY JOURNAL;

ANTICONVULSANTS; ELECTRON SPIN RESONANCE SPECTROSCOPY; FREE RADICAL SCAVENGERS; FREE RADICALS; HYDROXYL RADICAL; INDICATORS AND REAGENTS; ISOXAZOLES; NITRIC OXIDE; REFERENCE STANDARDS; SUPEROXIDES;

EID: 0031980480     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(97)00097-1     Document Type: Article

References (29)

1. ·NO through a radical reaction. Biochemistry. 32:1993;827-832.
2. Dowson V.L., Dawson T.M. Pathological roles of nitric dioxide in the central nervous system. Packer L., Hiramatsu M., Yoshikawa T. Free Radicals in Brain Physiology and Disorders. 1996;83-100 Academic Press, San Diego.
3. Endo A. Effect of zonisamide on neurotransmitter release from hippocampal slice of El mice: A study of neurotransmitter release using an improved experimental system. Okayama Igaku Zasshi. 107:1995;69-78. in Japanese.
4. Ferrendelli J.A., Blank A.C., Gross R.A. Relationships between seizure activity and cyclic nucleotide levels in brain. Brain Res. 200:1980;93-103.
5. Halliwell B., Gutterridge J.M.C. Free Radicals in Biology and Medicine. 2nd ed:1989;Clarendon Press, Oxford.
6. Hamada K., Ishida S., Yagi K., Seino M. Anticonvulsant effects of zonisamide on amygdaloid kindling in rats. Neurosciences. 16:1990;407-412.
7. Hammond E.J., Perchalski R.J., Wilder B.J. Neurophamacology of zonisamide, A new antiepileptic drug. Gen. Pharmacol. 18:1987;303-307.
8. Ito T., Hori M., Kadokawa T. Effects of zonisamide (AD-810) on tungstic acid gel-induced thalamic generalized seizures and conjugated estrogen-induced cortical spike-wave discharges in cats. Epilepsia. 27:1986;367-374.
9. Ito T., Hori M., Masuda Y., Yoshida K., Shimizu M. 3-Sulfamoylmethyl-1,2-benzeisoxazole: a new type of anticonvulsant drug. Electroencephalographic profile. Arzneim-Forsch. Drug Res. 30:1987;603-609.
10. Janzen E.G. Spin trapping. Packer L. Methods in Enzymology. 105:1986;188-198 Orlando, Florida.
11. Kitani K., Sato Y., Kanai S., Nokubo M., Ohta M., Masuda Y. Increasing anticonvulsant effects of AD-810 (zonisamide) in aging BDF1 mice. Life Sci. 41:1987;1339-1344.
12. Kito M., Maehara M., Watanabe K. Antiepileptic drugs-calcium current interaction in cultured human neuroblastoma cells. Seizure. 3:1994;141-149.
13. Komatsu M., Okamura Y., Hiramatsu M. Free radical scavenging activity of zonisamide and its inhibitory effect on lipid peroxide formation in iron-induced epileptogenic foci of rats. Neurosciences. 21:1995;23-29.
14. Manzoni O., Prezeau U., Marin P., Deshager S., Bockaert J., Fagni L. Nitric oxide-induced blockade of NMDA receptors. Neuron. 8:1992;654-662.
15. 14C]-methyl)-1,2-benzisoxazole (AD-810) in rats, dogs and monkeys and AD-810 in man. Arzneim-Forsch. Drug Res. 33:1983;961-968.
16. 14C-zonisamide in rat brain. Epilepsy Res. 17:1994;233-236.
17. Mori A. Reactive oxygen species and mechanism of induction of seizure by guanidino compound. Packer L., Hiramatsu M., Yoshikawa T. Free Radical in Brain Physiology and Disorders. 15:1996;3-15 Academic Press, San Diego.
18. Narahashi N., Tsunoo A., Yoshii M. Characterization of two types of calcium channels in mouse neuroblastoma cells. J. Physiol. 383:1987;231-249.
19. Noda Y., Anzai K., Mori A., Kohno M., Shimmei M., Packer L. Hydroxyl and superoxide anion radical scavenging activities of natural source antioxidants using the computerized JES-FR30 ESR spectrometer system. Biochem. Mol. Biol. Int. 42:1997;35-44.
20. 2+ dependent dopamine release. Epilepsy Res. 13:1992;113-119.
21. Okada M., Kaneko S., Hirano T., Mizuno K., Kondo T., Otani K., Fukushima Y. Effects of zonisamide on dopaminergic system. Epilepsy Res. 22:1995;193-205.
22. Rosen G.M., Rauckman E.J. Spin trapping of superoxide and hydroxyl radicals. Packer L. Methods in Enzymology. 105:1984;198-209 Academic Press, Orlando, Florida.
23. Sackellares J.C., Donofrio P.D., Wargner J.G., Abou-Khalil B., Berent S., Aasved-Hoyt K. Pilot study of zonisamide (1,2-benzisoxazole-3-methanesulfonamide) in patients with refractory partial seizures. Epilepsia. 26:1985;206-211.
24. Schauf C.L. Zonisamide enhances slow sodium inactivation in Myxicola. Brain Res. 413:1987;185-188.
25. Seino M., Miyazaki H., Ito T. Zonisamide. Pisani F., Perucca E., Avanzini G., Richens A. New Antiepileptic Drugs, Epilepsy Research. 1991;169-174 Elsevier, Amsterdam.
26. Suzuki S., Kawakami K., Nishimura S., Watanabe Y., Yagi K., Seino M., Miyamoto K. Zonisamide blocks T-type calcium channel in cultured neurons of rat cerebral cortex. Epilepsy Res. 12:1992;21-27.
27. Uno H., Kurokawa M., Natsuka K., Yamato Y., Nishimura H. Studies on 3-substituted 1,2-benzisoxazole derivatives, 1. Chem. Pharm. Bull. 24:1976;632-643.
28. Uno H., Kurokawa M., Masuda Y., Nishimura H. Studies on 3-substituted 1,2-benzisoxazole derivates. 6. Syntheses of 3-(sulfamoylmethyl)-1,2-benzisoxazole derivatives and their anticonvulsant activities. J. Med. Chem. 22:1979;180-191.
29. Wilensky A.J., Friel P.N., Ojemann L.M., Dodrill C.B., McCormick K.B., Levy R.H. Zonisamide in epilepsy: a pilot study. Epilepsia. 26:1985;212-220.